These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4630176)

  • 21. [Recurrences of pterygium after treatment. Our results with the local use of an antimitotic drug].
    Vitali G
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):753-69. PubMed ID: 4974138
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of pterygia with and without thiotepa.
    Colvin C
    Trans Ophthalmol Soc N Z; 1973; 25():67-9. PubMed ID: 4202569
    [No Abstract]   [Full Text] [Related]  

  • 23. Pterygium: "thiotepa" versus beta radiation, a double-blind trial.
    Harrison M; Kelly A; Ohlrich J
    Trans Aust Coll Ophthalmol; 1969; 1():64-6. PubMed ID: 4992945
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.
    Rachmiel R; Leiba H; Levartovsky S
    Br J Ophthalmol; 1995 Mar; 79(3):233-6. PubMed ID: 7703200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
    Edsmyr F; Boman J
    Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
    [No Abstract]   [Full Text] [Related]  

  • 26. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serious complications following topical administration of thio-tepa in a patient with bladder carcinoma].
    Kaczmarek A
    Wiad Lek; 1978 Apr; 31(8):547-50. PubMed ID: 96607
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraoperative application of topical mitomycin C 0.05% for pterygium surgery.
    Rodriguez JA; Ferrari C; Hernández GA
    Bol Asoc Med P R; 2004; 96(2):100-2. PubMed ID: 15580913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal N, N', N"-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: phase I-II study.
    Gutin PH; Weiss HD; Wiernik PH; Walker MD
    Cancer; 1976 Oct; 38(4):1471-5. PubMed ID: 825215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
    Madrigal Alonso PL; Perez Gomez FJ
    Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREVENTION ON RECURRENCE OF PTERYGIUM.
    MEACHAM CT
    Eye Ear Nose Throat Mon; 1965 May; 44():62-6 PASSIM. PubMed ID: 14291507
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in the functional state of the liver following endolymphatic administration of massive doses of thio-TEPA to patients with cancer of the uterine cervix].
    Moshkov BM; Ivanov OA
    Pediatr Akus Ginekol; 1972; 3():56-8. PubMed ID: 4633214
    [No Abstract]   [Full Text] [Related]  

  • 35. Triethylene thiophosphoramide in the prevention of pterygium recurrence.
    MEACHAM CT
    Am J Ophthalmol; 1962 Nov; 54():751-3. PubMed ID: 13934284
    [No Abstract]   [Full Text] [Related]  

  • 36. Pterygium surgery with mitomycin and tarsorrhaphy.
    Wood TO; Williams EE; Hamilton DL; Williams BL
    Trans Am Ophthalmol Soc; 2005; 103():108-14; discussion 114-5. PubMed ID: 17057794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
    Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
    J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of recurrent pterygia.
    Whaites JM
    Med J Aust; 1971 Apr; 1(14):739-40. PubMed ID: 4995071
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion.
    Lokich JJ; Egorin MJ; Cohen BE; Bern MM; Zipoli TE; Moore C
    Cancer; 1989 Jan; 63(1):46-50. PubMed ID: 2491952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.